The Metabolic Effects of a High Fructose Versus a High Glucose Diet in Overweight Men

July 3, 2012 updated by: University of Nottingham

Dietary consumption of fructose has increased by nearly 50% since 1960.

A high fructose diet (HFrD) results in greater visceral adiposity and systemic insulin resistance than a high glucose diet. The effects of fructose on liver fatty acid and ATP stores, systemic oxidative stress and cardiovascular status are not fully known.

Study Overview

Detailed Description

The protocol will assess the following outcomes:

  1. The ultimate fate of this increased hepatic fatty acid production following a high fructose vs. glucose diet
  2. The effect of a high fructose vs. glucose diet on liver ATP stores
  3. The effect of a high fructose vs. glucose diet on markers of oxidative stress
  4. The effect of a high fructose vs. glucose diet on cardiovascular status

Factors critical to carbohydrate metabolism such as systemic insulin resistance, body composition, energy expenditure, physical activity will also be assessed.

32 centrally overweight healthy males with a low baseline fructose intake will be recruited. They will be randomised double blindly to receive 25% of their dietary energy requirements from either fructose or glucose for 14 days.

The sugars will first be taken in an energy balanced and then an overfeeding setting.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nottinghamshire
      • Nottingham, Nottinghamshire, United Kingdom, NG7 2UH
        • School of Biomedical Sciences, University of Nottingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  1. Body mass index 25-32
  2. Waist > hip circumference
  3. Age 18-50 years
  4. Male

Exclusion Criteria:

  1. Reported weight change > 3 kg in prior 3/12
  2. Active health problems
  3. Contraindications to MRI scanning
  4. Symptoms of functional bloating or irritable bowel syndrome
  5. Abnormal liver or renal function tests
  6. Random glucose greater than 11.0 mmol/L
  7. Evidence of metabolic or viral liver disease as screened for by hepatitis B and C serology, and ferritin.
  8. Alcohol intake > 21 units per week
  9. Vegetarianism
  10. Normal daily fructose intake from drinks greater than that in 500ml of coca cola
  11. Abnormal carbohydrate energy contribution to baseline diet - defined as greater than 2 standard deviations from the mean of the National Diet and Nutrition Survey 2002 data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: fructose
25% dietary energy from fructose
25% of dietary energy from fructose or glucose
Active Comparator: glucose
25% dietary energy from glucose
25% of dietary energy from fructose or glucose

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Liver triglyceride content
Time Frame: 2 weeks
2 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Muscle triglyceride content
Time Frame: 2 weeks
2 weeks
Total abdominal visceral fat content (MRI)
Time Frame: 2 weeks
2 weeks
Liver ATP, PME concentration and pH (31P MRS)
Time Frame: 2 weeks
2 weeks
Liver de novo lipogenesis
Time Frame: 2 weeks
2 weeks
Resting energy expenditure, lipid and carbohydrate oxidation rates
Time Frame: 2 weeks
2 weeks
Hepatic and systemic insulin resistance
Time Frame: 2 weeks
2 weeks
Cardiovascular measures using finometry
Time Frame: 2 weeks
2 weeks
Systemic oxidative stress and inflammatory cytokine profile
Time Frame: 2 weeks
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ian A Macdonald, PhD, School of Biomedical Sciences, Nottingham University, UK
  • Principal Investigator: Richard D Johnston, MRCP, School of Biomedical Sciences, Nottingham University, UK

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2010

Primary Completion (Actual)

December 1, 2010

Study Completion (Actual)

April 1, 2011

Study Registration Dates

First Submitted

January 14, 2010

First Submitted That Met QC Criteria

January 14, 2010

First Posted (Estimate)

January 15, 2010

Study Record Updates

Last Update Posted (Estimate)

July 4, 2012

Last Update Submitted That Met QC Criteria

July 3, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oxidative Stress

Clinical Trials on high sugar diet

3
Subscribe